Physician profile
Patrick E Mcgregor
NPI 1295734481
$6,793.24
in general payments reported to CMS, 2019-2025
9 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,014 · 2022: $3,042 · 2023: $167 · 2024: $934 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,138 · Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,138.01 |
| Food and Beverage | $599.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,998.73 | 2019-2022 | |
| Medline Industries Lp | $934.11 | 2024 | |
| Stryker Corporation | $465.25 | 2025 | Infinity |
| Trilliant Surgical LLC. | $151.50 | 2025 | Arsenal Sinus Support Plate |
| Kerecis Limited | $87.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $79.55 | 2023 | Irrisept |
| Merck Sharp & Dohme LLC | $34.45 | 2019-2025 | Bridion |
| Ambu INC. | $30.00 | 2022 | |
| Medtronic, INC. | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcgregor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.